AACR Annual Meeting | April 8-13, 2022
Biond Biologics gave an oral presentation for BND-67, an Inhibitor of CD28 shedding, a potential novel resistance mechanism to anti PD-1 therapies, at the American Association for Cancer Research (AACR) 2022 in New Orleans, Louisiana.
Biond gave the oral presentation in the session of: “Experimental and Molecular Therapeutics – Elucidating Disease Biology and Drug Resistance Mechanisms”. The presentation title was: “CD28 shedding is a novel resistance mechanism to anti PD-1 therapy”, (Abstract #654)